Hypersensitivity is a poorly understood phenomenon thought to result from opioid-induced neuroplastic changes

in the peripheral and central nervous systems that lead to sensitization of pronociceptive pathways [1,9]. Little data exist to support the long-term efficacy of opioids or to describe the relation between opioid dose and the length of exposure among chronic opioid users [10]. Although randomized controlled trials have evaluated opioids for the treatment of chronic pain, most of these trials have limited follow-up periods (around 16 weeks) [3-5] and in the trials with longer follow-up periods, the Inhibitors,research,lifescience,medical lack of generalizability of the findings has been identified as a serious shortcoming [4]. Claims databases provide an opportunity to close this gap in knowledge. These databases are a collection of health insurance claims that are maintained largely for billing and administrative purposes. Nevertheless, they permit the evaluation of not Inhibitors,research,lifescience,medical only a diverse

population, but also a large number of subjects followed over a relatively long Inhibitors,research,lifescience,medical period of time in a real-world setting [11]. Health care databases have been used extensively for pharmacoepidemiologic research in many therapeutic areas including pain [12-14] to describe health care utilization, patterns of care, disease prevalence, drug and disease outcomes, and cost of care. There are, however, limitations to the use of health care databases for pharmacoepidemiologic research: they are observational, which limits inferences Inhibitors,research,lifescience,medical about treatment efficacy relative to studies that include random allocation to treatment [11]; they may not include information on Buparlisib datasheet important confounding factors (eg, smoking), and they may include diagnoses that are provisional or whose selection may be Inhibitors,research,lifescience,medical affected by reimbursement policies. The advantages to the use of these databases

are the availability of systematic and accurate information on prescribed medications [11], their ability to follow patients for from many years, and the fact that they reflect clinical practice in a population that is not subject to the same selection biases as might apply to those who volunteered for inclusion in a study. In fact, health care databases often are used to explain differences in findings between trial data and clinical practice [15]. We sought to characterize the dose of opioids in both cancer and noncancer patients intermittently and chronically exposed to opioids using PharMetrics Patient-Centric database. PharMetrics is the largest health care claims database in the United States and is representative of the commercially insured population.